Clinical Trials Directory

Trials / Unknown

UnknownNCT03232554

Buxue Yimu Pills for Gynecological Iron-Deficiency Anemia

Clinical Observation of The Gynecological Iron-Deficiency Anemia Treated With Buxue Yimu Pills

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

This study evaluates Buxue Yimu Pills,Ferrous Sulfate and the addition of Buxue Yimu Pills to Ferrous Sulfate in the treatment of Iron-Deficiency Anemia in adults women. One third of participanta will receive Buxue Yimu Pills, one third of participanta will receive Buxue Yimu Pills, one third of participanta will receive Ferrous Sulfate,and the another third will receive Buxue Yimu Pills and Ferrous Sulfate in combination.

Detailed description

Buxue Yimu Pills, Ferrous Sulfate each Improve anemia, but they do so by different machanisms. We generally treat patients with uncomplicated Iron Deficiency Anemia with oral iron due to the ease of administration,and Ferrous Sulfate is one of the most commonly used drugs. Buxue Yimu Pills consists of multiple chinses herbs including Angelica Sinensis,Astragalus,Donkey-Hide Gelatin,Herba Leonuri,Citrus etc., which gains widespread application in the treatment after women's abortion or operations of uterine cavity. Based on the characteristics above, we try to explore its clinical application value in Gynecological Iron-Deficiency Anemia.

Conditions

Interventions

TypeNameDescription
DRUGBuxue Yimu PillsBuxue Yimu Pills 12g pill by mouth, twice daily.
DRUGBuxue Yimu Pills &Ferrous SulfateBuxue Yimu Pills 12g pill by mouth, twice daily and Ferrous Sulfate 0.3g tablet by mouth, three times daily
DRUGFerrous SulfateFerrous Sulfate 0.3g tablet by mouth, three times daily

Timeline

Start date
2017-06-01
Primary completion
2018-12-31
Completion
2019-02-28
First posted
2017-07-28
Last updated
2018-02-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03232554. Inclusion in this directory is not an endorsement.